Opportunity
Simpler Grants.gov #PAR-25-081
NCI Solicits Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Buyer
National Cancer Institute
Posted
November 12, 2024
Respond By
January 07, 2027
Identifier
PAR-25-081
NAICS
541715
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is inviting proposals for early phase clinical trials targeting cancer treatment and diagnosis. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Division of Cancer Treatment and Diagnosis (DCTD) - Office of HIV and AIDS Malignancy (OHAM) - Scope of Work: - Investigator-initiated early phase (Phase 0, I, II) clinical trials - Focus on cancer-targeted diagnostic and therapeutic interventions - Projects must include at least one clinical trial relevant to NCI research programs (e.g., Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary Research Program, HIV and AIDS Malignancies Research Program) - Eligibility: - Open to businesses, nonprofits, government entities, educational institutions, and other organizations - Funding Details: - Minimum funding amount: $499,999 - No cost sharing or matching required - Unique Requirements: - Projects must align with the scientific interests of NCI research programs - No specific OEMs or vendors are named, as this is a grant for research services, not product procurement
Description
The National Cancer Institute (NCI) is seeking research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions relevant to the research mission of DCTD and OHAM. The project must involve at least one clinical trial related to the scientific interests of specified NCI research programs including Cancer Therapy Evaluation, Cancer Imaging, Cancer Diagnosis, Radiation Research, Complementary, and HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial alone or combined with other research aims. The funding opportunity supports a wide range of eligible applicants including businesses, nonprofits, governments, educational institutions, and other organizations.